Evidence map›Paper›PMID 41755641›Full record

ArticleNucleic acids research2026

CELF1 is a non-canonical eIF4E binding protein that promotes translation of epithelial-mesenchymal transition effector mRNAs.

Arindam Chaudhury, Natee Kongchan, Shebna A Massey, Rajesh Sharma, Rituraj Pal, Na Zhao, Phoebe Tsoi, Yingmin Zhu, Emuejevoke Olokpa, Sufeng Mao and 8 more

Abstract read
In one paragraph

Article in Nucleic acids research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Arindam ChaudhuryDepartment of Integrative Physiology, Baylor College of Medicine, Houston, TX 77030, United States.
Natee KongchanDepartment of Integrative Physiology, Baylor College of Medicine, Houston, TX 77030, United States.
Shebna A MasseyDepartment of Integrative Physiology, Baylor College of Medicine, Houston, TX 77030, United States.
Rajesh SharmaDan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX 77030, United States.
Rituraj PalDepartment of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX 77030, United States.
Na ZhaoDan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX 77030, United States.ORCID 0000-0002-8161-3380
Phoebe TsoiDan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX 77030, United States.
Yingmin ZhuDepartment of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX 77030, United States.
Emuejevoke OlokpaDepartment of Integrative Physiology, Baylor College of Medicine, Houston, TX 77030, United States.
Sufeng MaoDan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX 77030, United States.
Sonia Del RinconGerald Bronfman Department of Oncology, McGill University, Lady Davis Institute for Medical Research, Segal Cancer Centre of the Jewish General Hospital, Montreal, Quebec H3T 1E2, Canada.
Lucas C ReinekeDepartment of Integrative Physiology, Baylor College of Medicine, Houston, TX 77030, United States.
Richard E LloydDan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX 77030, United States.
Marco SardielloDepartment of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX 77030, United States.
Jeffrey M RosenDan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX 77030, United States.
Choel KimDan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX 77030, United States.
Josephine C FerreonDan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX 77030, United States.
Joel R NeilsonDepartment of Integrative Physiology, Baylor College of Medicine, Houston, TX 77030, United States.ORCID 0000-0002-3408-608X

Funding

Adrienne Helis Malvin Medical Research FoundationNCI NIH HHS CA190467Samuel Waxman Cancer Research Foundation RSG-15-088-01RMC
6 · The paper itself

Abstract

Mounting evidence is revealing an increasing complexity of gene regulation at the level of messenger RNA (mRNA) translation. Within mammalian cells, canonical cap-dependent mRNA translation depends on the eIF4F complex, consisting of the m7G mRNA cap-binding protein eukaryotic initiation factor 4E (eIF4E), the helicase eIF4A (eIF4A), and the eIF4G (eIF4G1) scaffolding protein. eIF4G1 additionally binds poly(A) binding protein (PABPC1) to facilitate mRNA circularization and nucleates pre-translation initiation complex assembly to initiate ribosomal scanning. In breast epithelial cells, the CELF1 RNA-binding protein specifically promotes the translation of select epithelial-to-mesenchymal transition (EMT) effector mRNAs by binding GU-rich elements (GREs) within their 3' untranslated regions (UTRs). Here we show that CELF1 directly binds to both eIF4E and PABPC1 to promote eIF4G1-independent translation of GRE-containing mRNAs in mesenchymal cells. Disruption of this CELF1/eIF4E interaction inhibits both EMT induction in vitro and experimental metastasis in vivo. Our findings define a novel, non-canonical mode of translational regulation underlying cellular de-differentiation, raising the possibility that analogous non-canonical modes of translation impact additional transitional cellular states within development and disease.

Indexed as

CELF1 ProteinEpithelial-Mesenchymal TransitionEukaryotic Initiation Factor-4EProtein BiosynthesisRNA, Messenger3' Untranslated RegionsAnimalsCell Line, TumorEukaryotic Initiation Factor-4GFemaleHumansPoly(A)-Binding Protein IProtein Binding3' Untranslated RegionsCELF1 ProteinCELF1 protein, humanEIF4E protein, humanEIF4G1 protein, humanEukaryotic Initiation Factor-4EEukaryotic Initiation Factor-4GPoly(A)-Binding Protein IRNA, Messenger

Identifiers

PMID41755641
PMCPMC12956340

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.